Arrowhead Pharmaceuticals, Inc. (FRA:HDP1)
52.64
-2.74 (-4.95%)
At close: Dec 5, 2025
Arrowhead Pharmaceuticals Market Cap
Arrowhead Pharmaceuticals has a market cap or net worth of €7.17 billion as of December 5, 2025. Its market cap has increased by 220.63% in one year.
Market Cap
7.17B
Enterprise Value
7.05B
Revenue
706.94M
Ranking
n/a
PE Ratio
n/a
Stock Price
€52.64
Market Cap Chart
Since January 13, 2004, Arrowhead Pharmaceuticals's market cap has increased from 25.96M to 7.17B, an increase of 27,525.13%. That is a compound annual growth rate of 29.25%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 248.18B |
| Siemens Aktiengesellschaft | 179.36B |
| Allianz SE | 139.43B |
| Deutsche Telekom AG | 131.24B |
| Siemens Energy AG | 99.98B |
| Rheinmetall AG | 70.18B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.26B |
| Deutsche Bank Aktiengesellschaft | 59.33B |